Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes

The Journal of Clinical Investigation
J W LendersH G Brunner

Abstract

Monoamine oxidase (MAO) exists as two isoenzymes and plays a central role in the metabolism of monoamine neurotransmitters. In this study we compared the neurochemical phenotypes of previously described subjects with genetically determined selective lack of MAO-A or a lack of both MAO-A and MAO-B with those of two subjects with a previously described X chromosome microdeletion in whom we now demonstrate selective MAO-B deficiency. Mapping of the distal deletion breakpoint demonstrates its location in intron 5 of the MAO-B gene, with the deletion extending proximally into the Norrie disease gene. In contrast to the borderline mental retardation and abnormal behavioral phenotype in subjects with selective MAO-A deficiency and the severe mental retardation in patients with combined MAO-A/MAO-B deficiency and Norrie disease, the MAO-B-deficient subjects exhibit neither abnormal behavior nor mental retardation. Distinct neurochemical profiles characterize the three groups of MAO-deficient patients. In MAO-A-deficient subjects, there is a marked decrease in deaminated catecholamine metabolites and a concomitant marked elevation of O-methylated amine metabolites. These neurochemical changes are only slightly exaggerated in patients wi...Continue Reading

References

Jan 6, 1977·Nature·V GloverG J Riley
May 1, 1977·Biochemical Pharmacology·C H Donnelly, D L Murphy
May 1, 1992·Human Molecular Genetics·K B SimsX O Breakefield
Jun 1, 1992·Nature Genetics·W BergerM Warburg
Jan 1, 1991·Journal of Neural Transmission. General Section·D L MurphyX O Breakefield
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J GrimsbyJ C Shih
Jan 1, 1990·Pharmacology & Therapeutics·W WeylerX O Breakefield
Oct 1, 1988·Journal of Neurochemistry·G EisenhoferI J Kopin
Feb 1, 1988·Journal of Medical Genetics·D DonnaiA P Read
Nov 1, 1988·Ophthalmic Paediatrics and Genetics·E M Bleeker-WagemakersA Gal
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Jan 1, 1986·Journal of Neuroscience Research·L M KocherspergerR M Denney
Jan 1, 1985·Psychopharmacology·T SunderlandD L Murphy
Dec 31, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·G M van KempenE J Pennings
May 1, 1984·Psychiatry Research·L von KnorringB Winblad
Feb 28, 1984·Clinica Chimica Acta; International Journal of Clinical Chemistry·N G AbelingP A Voûte
Oct 1, 1995·The Journal of Clinical Endocrinology and Metabolism·G EisenhoferJ W Lenders
Oct 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·P M Whitaker-AzmitiaC Clarke
Dec 1, 1994·Journal of the Autonomic Nervous System·G EisenhoferD S Goldstein
Feb 1, 1994·Progress in Neurobiology·M D BerryI A Paterson
Dec 15, 1993·American Journal of Medical Genetics·E J DevorB Tabakoff

❮ Previous
Next ❯

Citations

Mar 26, 2009·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Santhosh Girirajan, Sarah H Elsea
Jul 14, 2010·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·David S Goldstein
Oct 10, 2002·Biological Psychiatry·Jose Maria MejiaRoberta M Palmour
Apr 9, 1998·Biological Psychiatry·T E MoffittP Silva
Jan 29, 2003·Current Opinion in Pharmacology·Theresa A Branchek, Thomas P Blackburn
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marco BortolatoJean C Shih
Jul 17, 2013·Proceedings of the National Academy of Sciences of the United States of America·Chanpreet SinghJean C Shih
Jul 5, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·M MoldavskyT Lerman-Sagie
Oct 27, 2010·PloS One·Tatyana D SotnikovaRaul R Gainetdinov
Nov 19, 2013·PloS One·Emilia Horjales-AraujoLene Vase
Mar 28, 2013·Autism Research and Treatment·Shi-Sheng ZhouQiang Ma
Aug 7, 2009·Journal of Neural Transmission·Andrea M DlugosHarriet de Wit
Oct 6, 2004·Médecine sciences : M/S·Aline Ghozlan, Arnold Munnich
Feb 20, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Rona R Ramsay
Mar 27, 2015·Clinical Genetics·E E PalmerM Field
Mar 25, 2009·Pharmacological Reports : PR·Fabio Di LisaMarco Giorgio
Nov 18, 2015·The Journal of Pharmacology and Experimental Therapeutics·David S GoldsteinYehonatan Sharabi
Jun 19, 2010·Progress in Neurobiology·Esther M OpmeerAndré Aleman
Jan 24, 2009·Journal of Molecular and Cellular Cardiology·Olivier LairezJeanne Mialet-Perez
Mar 12, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jaanus Harro, Lars Oreland
May 23, 2008·Gene·Kyung-Won HongMiho Inoue-Murayama
Mar 26, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Lea K DavisThomas H Wassink
Apr 30, 2008·Human Mutation·Jan HaavikBeat Thöny
Feb 14, 2015·Journal of Labelled Compounds & Radiopharmaceuticals·Joanna S FowlerNora D Volkow
Nov 24, 2004·Autonomic Neuroscience : Basic & Clinical·Timothy OeltmannDavid Robertson
Apr 30, 2005·Trends in Pharmacological Sciences·Lothar Lindemann, Marius C Hoener
Mar 6, 2003·Neurologic Clinics·Kathryn J Swoboda, Keith Hyland
Aug 12, 1999·American Journal of Human Genetics·J C Shih, R F Thompson
Sep 24, 2015·Nature Reviews. Neurology·Joanne NgManju A Kurian
Jul 22, 2015·Pediatric Neurology·Lance H RodanPhillip L Pearl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.